Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
Status:
Recruiting
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
This international, multicentre, pragmatic, double-blind, placebo-controlled, randomised
trial of TxA versus placebo will enrol 3,300 patients throughout Australia and
internationally. This is an effectiveness trial - some elements of the trial are deliberately
left to the perioperative clinicians' discretion in order to reflect usual practice and
maximise generalisability.
Phase:
Phase 4
Details
Lead Sponsor:
Bayside Health
Collaborator:
National Health and Medical Research Council, Australia